The IPO Queue Fills Up, But A Recovery Is A Way Off
Six biopharma companies have filed to list their shares on US exchanges so far this year, but the sums they are seeking are small.

Six biopharma companies have filed to list their shares on US exchanges so far this year, but the sums they are seeking are small.